1 |
Bacharova L, Kollarova M, Bezak B, Bohm A. Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers. Int J Mol Sci 2023;24. [PMID: 36835293 DOI: 10.3390/ijms24043881] [Reference Citation Analysis]
|
2 |
de Los Reyes-García AM, Zapata-Martínez L, Águila S, Lozano ML, Martínez C, González-Conejero R. microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation. Front Cardiovasc Med 2023;10:1135127. [PMID: 36895835 DOI: 10.3389/fcvm.2023.1135127] [Reference Citation Analysis]
|
3 |
Zhang L, Wang X, Huang C. A narrative review of non-coding RNAs in atrial fibrillation: potential therapeutic targets and molecular mechanisms. Ann Transl Med 2021;9:1486. [PMID: 34734038 DOI: 10.21037/atm-21-4483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Sygitowicz G, Maciejak-Jastrzębska A, Sitkiewicz D. A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation. J Clin Med 2021;10:4430. [PMID: 34640448 DOI: 10.3390/jcm10194430] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
|
5 |
Burg S, Attali B. Targeting of Potassium Channels in Cardiac Arrhythmias. Trends Pharmacol Sci 2021;42:491-506. [PMID: 33858691 DOI: 10.1016/j.tips.2021.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
6 |
Ruan ZB, Wang F, Yu QP, Chen GC, Zhu L. Integrative analysis of the circRNA-miRNA regulatory network in atrial fibrillation. Sci Rep 2020;10:20451. [PMID: 33235238 DOI: 10.1038/s41598-020-77485-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|